冠状动脉支架：新进展 - Suppr

Suppr

超能文献

Coronary stents: novel developments.

作者信息

Stefanini Giulio G, Taniwaki Masanori, Windecker Stephan

机构信息

Department of Cardiology, Bern University Hospital, Bern, Switzerland.

出版信息

Heart. 2014 Jul;100(13):1051-61. doi: 10.1136/heartjnl-2012-303522. Epub 2013 Sep 4.

DOI:10.1136/heartjnl-2012-303522

PMID:24006453

Abstract

摘要

相似文献

Coronary stents: novel developments.冠状动脉支架：新进展

Heart. 2014 Jul;100(13):1051-61. doi: 10.1136/heartjnl-2012-303522. Epub 2013 Sep 4.

The optimal treatment of STEMI: new pharmacological and device approaches.ST段抬高型心肌梗死（STEMI）的最佳治疗：新的药物和器械治疗方法。

Panminerva Med. 2013 Dec;55(4):339-43.

Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.尽管双联抗血小板治疗时间更短，但可生物降解聚合物与不可降解聚合物紫杉醇洗脱支架的临床安全性和疗效相当：来自多中心、倾向评分匹配登记研究的结果。

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E155-62. doi: 10.1002/ccd.24732. Epub 2012 Dec 3.

Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.通过光学相干断层扫描评估快速降解生物可降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架的早期血管愈合情况。

Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):84-9. doi: 10.1016/j.carrev.2012.12.003. Epub 2013 Jan 24.

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.新一代可生物降解聚合物涂层西罗莫司洗脱支架治疗冠状动脉疾病：CREATE 研究的最终 5 年临床结果。

EuroIntervention. 2012 Nov 22;8(7):815-22. doi: 10.4244/EIJV8I7A124.

Clinical efficacy and safety of biodegradable polymer-based sirolimus-eluting stents in patients with diabetes mellitus insight from the 4-year results of the create study.从 CREATE 研究 4 年结果看糖尿病患者应用载有西罗莫司的可生物降解聚合物涂层支架的临床疗效和安全性。

Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1127-33. doi: 10.1002/ccd.24649. Epub 2013 Feb 26.

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.无聚合物载药的西罗莫司和普罗布考洗脱支架与可生物降解聚合物西罗莫司洗脱支架治疗阻塞性冠状动脉疾病的比较：DKPLUS-Wave 1，一项多中心、随机、前瞻性试验。

Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x.

Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent thrombosis.西罗莫司洗脱支架植入4年后出现右冠状动脉“憩室病”，伴有极晚期支架血栓形成。

Heart. 2013 Nov;99(21):1627. doi: 10.1136/heartjnl-2013-304263. Epub 2013 Jun 7.

Bioresorbable vascular scaffolds: the shape of things to come?生物可吸收血管支架：未来的发展形态？

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):472-3. doi: 10.1002/ccd.24362. Epub 2012 Apr 27.

Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation.时间并不能治愈所有伤口：西罗莫司洗脱支架植入八年后发生极晚期支架内血栓形成，原因是阳性重塑、囊状膨出和显著的血管炎症。

EuroIntervention. 2013 Jul;9(3):412-3. doi: 10.4244/EIJV9I3A66.

引用本文的文献

Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 5-Year Outcomes From the BIONICS and NIREUS Trials.雷帕霉素洗脱和佐他莫司洗脱冠状动脉支架的比较：BIONICS 和 NIREUS 试验的 5 年结果。

J Am Heart Assoc. 2024 Nov 19;13(22):e036210. doi: 10.1161/JAHA.124.036210. Epub 2024 Nov 15.

A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting.一项关于生物可吸收聚合物药物洗脱支架与完全生物可吸收支架用于冠状动脉支架置入患者的前瞻性随机试验。

J Clin Med. 2024 Oct 7;13(19):5949. doi: 10.3390/jcm13195949.

A Study of PLA Thin Film on SS 316L Coronary Stents Using a Dip Coating Technique.使用浸涂技术对316L不锈钢冠状动脉支架上的聚乳酸薄膜进行的研究。

Polymers (Basel). 2024 Jan 19;16(2):284. doi: 10.3390/polym16020284.

Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents.载有依维莫司的超薄支架治疗动脉粥样硬化病变：最长支架亚组分析的 3 年随访结果

Indian Heart J. 2023 Jul-Aug;75(4):279-284. doi: 10.1016/j.ihj.2023.03.006. Epub 2023 Mar 25.

Effect of Parylene C on the Corrosion Resistance of Bioresorbable Cardiovascular Stents Made of Magnesium Alloy 'Original ZM10'.聚对二甲苯C对镁合金“原始ZM10”制成的生物可吸收心血管支架耐腐蚀性的影响

Materials (Basel). 2022 Apr 26;15(9):3132. doi: 10.3390/ma15093132.

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction.急性心肌梗死患者超过12个月的单药和双联抗血小板治疗对缺血风险的临床影响

Front Cardiovasc Med. 2021 Nov 24;8:783344. doi: 10.3389/fcvm.2021.783344. eCollection 2021.

Early- and Middle-Phase Angioscopic Assessment of Arterial Healing Following Current Drug-Eluting Stent Implantation in Patients With Acute Coronary Syndrome.急性冠状动脉综合征患者当前药物洗脱支架植入术后动脉愈合的早期和中期血管内镜评估

Circ Rep. 2021 Oct 1;3(11):666-673. doi: 10.1253/circrep.CR-21-0113. eCollection 2021 Nov 10.

Coronary In-Stent Restenosis: Predictors and Treatment.冠状动脉支架内再狭窄：预测因素与治疗。

Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254.

Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients.超薄（60μm）、超长（≥40mm）西罗莫司洗脱支架：真实世界患者临床和安全性特征研究。

Anatol J Cardiol. 2021 Feb;25(2):111-119. doi: 10.14744/AnatolJCardiol.2020.40909.

Clinical safety and efficacy of World's thinnest (50 μm), very long (>40 mm) Everolimus Eluting Stent (SES) among real world patients.世界上最薄（50微米）、非常长（>40毫米）的依维莫司洗脱支架（SES）在真实世界患者中的临床安全性和有效性。

Am J Cardiovasc Dis. 2020 Oct 15;10(4):317-328. eCollection 2020.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验